Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

COVID travel update: Double jabbed from US and EU could avoid UK quarantine

July 30, 2021 Medical Communications

UK ministers are close to deciding that double vaccinated people from the US and many EU countries will not have …
News

Positive data reported on Alnylam’s investigational RNAi therapeutic for ultra-rare disease

July 30, 2021 Medical Communications

Alnylam Pharmaceuticals has announced that its investigational RNAi therapeutic, lumasiran, has performed well in a Phase III study for the …
News

FDA grants Huntingdon disease treatment orphan-drug designation

July 30, 2021 Medical Communications

The FDA has granted VICO’s investigational therapy for Huntingdon disease, VO659, orphan-drug designation. This news comes just one month after …
News

Tokyo daily COVID cases hit record high

July 27, 2021 Manufacturing and Production, Medical Communications

On Tuesday Tokyo reported 2,848 daily coronavirus infections, the city’s highest rate since the pandemic began. The new infection record …
News

Antibodies from Sinovac’s COVID-19 vaccine fade after 6 months, study finds

July 27, 2021 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

A Chinese laboratory study has found that antibodies from Sinovac Biotech’s COVID-19 vaccine drop below a key threshold around six …
News

New NICE guideline on C. difficile rejects metronidazole prescription

July 23, 2021 Medical Communications

NICE has published a new guideline covering C. difficile infection, the latest in the series of antimicrobial prescribing guidelines which …
News
pfizer_building_logo2_1

Eight-week vaccine gap with Pfizer is best for antibodies

July 23, 2021 Medical Communications

UK researchers have found an eight-week gap between first and second doses of the Pfizer-BioNTech appears to be the “sweet …
News

Expansion for first FDA-approved video game for ADHD treatment

July 23, 2021 Medical Communications, Research and Development ADHD, FDA, US, digital therapeutics, technology

Akili Interactive has announced the expansion of its prescription video game treatment, EndeavorRx, with the addition of new gaming features …
News

Biogen pens open letter to Alzheimer’s community

July 23, 2021 Medical Communications

In the wake of the controversial approval of Biogen’s Alzheimer’s drug, Aduhelm, the company has penned an open letter to …
News

Parents warned as child respiratory illness on the rise this summer

July 23, 2021 Medical Communications

Parents are being warned to be on the lookout for signs of a common childhood respiratory illness, RSV, as cases …
News
cdc-un8tv9pw2ik-unsplash_1

Two shots of Pfizer or AstraZeneca vaccine are effective against Delta variant

July 22, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

A new study has shown that two shots of either Pfizer or AstraZeneca’s COVID-19 vaccine are nearly as effective against …
News
roche__tree

Roche discussing potential Alzheimer’s treatment with FDA

July 22, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Roche is discussing its potential treatment, gantenerumab, for Alzheimer’s disease with the FDA as clinical trials proceed. Chief Executive Severin …
News

NICE approves treatment for rare bile duct cancer

July 22, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

NICE has approved Pemigatinib (Pemazyre) as first treatment for people with a rare form of bile duct cancer (cholangiocarcinoma). Pemigatinib, …
News

J&J ‘one shot’ vaccine ineffective against Delta variant, study finds

July 21, 2021 Medical Communications, Research and Development

A new study posted online on Tuesday, has found that Johnson & Johnson’s COVID-19 vaccine is much less effective against …
News

Pfizer to pay $345 million in EpiPen lawsuit

July 16, 2021 Medical Communications Mylan, Pfizer, epipen

Pfizer has reached a $345 million settlement over consumer claims they overpaid for EpiPens as a result of unfair, anticompetitive …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025